Business Description
Cochlear Ltd
NAICS : 339113
ISIN : AU000000COH5
Description
Cochlear is the leading cochlear implant device manufacturer with around 60% global market share. Developed markets contribute 80% of group revenue where cochlear implants are the standard of care for children with severe to profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2020, 49% of revenue came from the Americas, 35% from Europe, the Middle East, and Africa, and 16% from the Asia-Pacific segment.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.75 | |||||
| Equity-to-Asset | 0.68 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | 0.41 | |||||
| Interest Coverage | 33.18 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 14.36 | |||||
| Beneish M-Score | -2.37 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.9 | |||||
| 3-Year Book Growth Rate | 7.7 | |||||
| Future 3-5Y Total Revenue Growth Rate | 9.05 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 22.08 | |||||
| 9-Day RSI | 33.53 | |||||
| 14-Day RSI | 43.47 | |||||
| 6-1 Month Momentum % | 17.34 | |||||
| 12-1 Month Momentum % | 31.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.36 | |||||
| Quick Ratio | 1.82 | |||||
| Cash Ratio | 0.96 | |||||
| Days Inventory | 216.26 | |||||
| Days Sales Outstanding | 69.42 | |||||
| Days Payable | 175.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.27 | |||||
| Dividend Payout Ratio | 0.66 | |||||
| 3-Year Dividend Growth Rate | 19.7 | |||||
| Forward Dividend Yield % | 1.35 | |||||
| 5-Year Yield-on-Cost % | 1.22 | |||||
| Shareholder Yield % | 1.54 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 74.79 | |||||
| Operating Margin % | 16.11 | |||||
| Net Margin % | 15.53 | |||||
| ROE % | 17.51 | |||||
| ROA % | 12.02 | |||||
| ROIC % | 14 | |||||
| ROC (Joel Greenblatt) % | 57.69 | |||||
| ROCE % | 20.54 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 56.19 | |||||
| Forward PE Ratio | 46.95 | |||||
| PE Ratio without NRI | 56.19 | |||||
| Shiller PE Ratio | 75.67 | |||||
| Price-to-Owner-Earnings | 54.45 | |||||
| PS Ratio | 8.73 | |||||
| PB Ratio | 9.62 | |||||
| Price-to-Tangible-Book | 12.9 | |||||
| Price-to-Free-Cash-Flow | 63.45 | |||||
| Price-to-Operating-Cash-Flow | 46.65 | |||||
| EV-to-EBIT | 40.56 | |||||
| EV-to-Forward-EBIT | 34.94 | |||||
| EV-to-EBITDA | 33.82 | |||||
| EV-to-Forward-EBITDA | 30.27 | |||||
| EV-to-Revenue | 8.51 | |||||
| EV-to-Forward-Revenue | 7.63 | |||||
| EV-to-FCF | 62.34 | |||||
| Price-to-Projected-FCF | 5.94 | |||||
| Price-to-Median-PS-Value | 1.11 | |||||
| Price-to-Graham-Number | 5.68 | |||||
| Price-to-Net-Current-Asset-Value | 31.07 | |||||
| Earnings Yield (Greenblatt) % | 2.46 | |||||
| Forward Rate of Return (Yacktman) % | 21.08 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cochlear Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 1,936.1 | ||
| EPS (TTM) (A$) | 4.561 | ||
| Beta | 0.81 | ||
| Volatility % | 21.81 | ||
| 14-Day RSI | 43.47 | ||
| 14-Day ATR (A$) | 4.32599 | ||
| 20-Day SMA (A$) | 265.756 | ||
| 12-1 Month Momentum % | 31.09 | ||
| 52-Week Range (A$) | 184.62 - 274.65 | ||
| Shares Outstanding (Mil) | 65.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cochlear Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cochlear Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cochlear Ltd Frequently Asked Questions
What is Cochlear Ltd(ASX:COH)'s stock price today?
The current price of ASX:COH is A$256.32. The 52 week high of ASX:COH is A$274.65 and 52 week low is A$184.62.
When is next earnings date of Cochlear Ltd(ASX:COH)?
The next earnings date of Cochlear Ltd(ASX:COH) is 2024-02-14 Est..
Does Cochlear Ltd(ASX:COH) pay dividends? If so, how much?
The Dividend Yield %  of Cochlear Ltd(ASX:COH) is 1.27% (As of Today), Highest Dividend Payout Ratio of Cochlear Ltd(ASX:COH) was 1.55. The lowest was 0.23. And the median was 0.66. The  Forward Dividend Yield % of Cochlear Ltd(ASX:COH) is 1.35%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers